PMID: 9430182Jan 16, 1998Paper

Issues relating to the inclusion of high-dose chemotherapy in breast cancer treatment guidelines

Oncology
M J Kennedy

Abstract

The development of guidelines for the use of high-dose chemotherapy in the treatment of breast cancer is a challenging task. The absence of large amounts of data from prospective, randomized, phase III clinical trials, and the variability of patient populations and treatment strategies in phase II studies mean that these guidelines have to be developed in the absence of conclusive clinical data. Nonetheless, the available information suggests strategies for incorporating this therapy into the care of certain patients with breast cancer.

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.